Genomic surveillance has proven to be a critical source of information for understanding and responding to the COVID-19 pandemic. In Africa, genomic surveillance was very limited, and few sequences are available on GISAID database. Many initiatives, including WHO and other international partners, have been working to build capacity, particularly in low-income countries, to implement genomic surveillance. The AFROSCREEN project is about structuring an African network to build the capacities of laboratories, share data and effectively monitor the circulation of viruses. The aim of this study is to show the contribution of the WHO and AFROSCREEN project in the implementation of genomic surveillance of SARS-CoV-2 in the Ivory Coast. The acquisition of a MinION Mk1C sequencer from Oxford nanopore technology and training in sequencing and sequence analysis have enabled 395 sequences to be obtained. Of the 395 samples sequenced, 241 (61.01%) sequences yielded high-quality genomic data, achieving ≥95% genome coverage with a read depth of 30X and greater. These 241 sequences have passed quality control and have been deposited in the Global initiative on sharing of all influenza data (GISAID. In conclusion, support from the AFROSCREEN Project and WHO has enabled us to set up a platform for genomic surveillance of SARS-CoV-2 in C？te d’Ivoire. Nanopore sequencing is an easy method to implement, even for laboratories with limited NGS experience.
References
[1]
Freed, N.E., Vlková, M., Faisal, M.B. and Silander, O.K. (2020) Rapid and Inexpensive Whole-Genome Sequencing of SARS-CoV-2 Using 1200 bp Tiled Amplicons and Oxford Nanopore Rapid Barcoding. Biology Methods and Protocols, 5, bpaa014. https://doi.org/10.1093/biomethods/bpaa014
[2]
Loman, N.J., Rowe, W. and Rambaut, A. (2020) nCoV-2019 Novel Coronavirus Bioinformatics Protocol. https://artic.network/ncov-2019/ncov2019-bioinformatics-sop.html
[3]
Baker, D.J., Aydin, A., Le-Viet, T., Kay, G.L., Rudder, S., de Oliveira Martins, L., et al. (2021) Coronahit: High-Throughput Sequencing of SARS-CoV-2 Genomes. Genome Medicine, 13, Article No. 21. https://doi.org/10.1186/s13073-021-00839-5
[4]
Criscuolo, A. and Gribaldo, S. (2010) BMGE (Block Mapping and Gathering with Entropy): A New Software for Selection of Phylogenetic Informative Regions from Multiple Sequence Alignments. BMC Evolutionary Biology, 10, Article No. 210. https://doi.org/10.1186/1471-2148-10-210
[5]
Katoh, K. and Standley, D.M. (2013) MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability. Molecular Biology and Evolution, 30, 772-780. https://doi.org/10.1093/molbev/mst010
[6]
Minh, B.Q., Schmidt, H.A., Chernomor, O., Schrempf, D., Woodhams, M.D., von Haeseler, A., et al. (2020) IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era. Molecular Biology and Evolution, 37, 1530-1534. https://doi.org/10.1093/molbev/msaa015
[7]
Walls, A.C., Park, Y., Tortorici, M.A., Wall, A., McGuire, A.T. and Veesler, D. (2020) Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell, 181, 281-292.E6. https://doi.org/10.1016/j.cell.2020.02.058
[8]
Hsieh, C., Goldsmith, J.A., Schaub, J.M., DiVenere, A.M., Kuo, H., Javanmardi, K., et al. (2020) Structure-Based Design of Prefusion-Stabilized SARS-CoV-2 Spikes. Science, 369, 1501-1505. https://doi.org/10.1126/science.abd0826
[9]
World Health Organization (2021) Coronavirus (COVID-19) Dashboard. https://data.who.int/dashboards/covid19/cases?n=c
[10]
Sy, K.T.L., White, L.F. and Nichols, B.E. (2021) Population Density and Basic Reproductive Number of COVID-19 across United States Counties. PLOS ONE, 16, e0249271. https://doi.org/10.1371/journal.pone.0249271
[11]
Bogoch, I.I., Watts, A., Thomas-Bachli, A., Huber, C., Kraemer, M.U.G. and Khan, K. (2020) Pneumonia of Unknown Aetiology in Wuhan, China: Potential for International Spread via Commercial Air Travel. Journal of Travel Medicine, 27, taaa008. https://doi.org/10.1093/jtm/taaa008
[12]
Centers for Disease Control and Prevention (2021) Coronavirus Disease 2019 (COVID-19). https://www.cdc.gov/coronavirus/2019-ncov/variants/genomic-surveillance.html
[13]
Coronaviridae Study Group of the International Committee on Taxonomy of Viruses (2020) The Species Severe Acute Respiratory Syndrome-Related Coronavirus: Classifying 2019-nCoV and Naming It SARS-CoV-2. Nature Microbiology, 5, 536-544. https://doi.org/10.1038/s41564-020-0695-z
[14]
Marcenac, P., McCarron, M., Davis, W., Igboh, L.S., Mott, J.A., Lafond, K.E., et al. (2022) Leveraging International Influenza Surveillance Systems and Programs during the COVID-19 Pandemic. Emerging Infectious Diseases, 28, 26-33. https://doi.org/10.3201/eid2813.212248
[15]
Shu, B., Kirby, M.K., Davis, W.G., Warnes, C., Liddell, J., Liu, J., et al. (2021) Multiplex Real-Time Reverse Transcription PCR for Influenza a Virus, Influenza B Virus, and Severe Acute Respiratory Syndrome Coronavirus 2. Emerging Infectious Diseases, 27, 1821-1830. https://doi.org/10.3201/eid2707.210462
[16]
Quick, J., Grubaugh, N.D., Pullan, S.T., Claro, I.M., Smith, A.D., Gangavarapu, K., et al. (2017) Multiplex PCR Method for Minion and Illumina Sequencing of Zika and Other Virus Genomes Directly from Clinical Samples. Nature Protocols, 12, 1261-1276. https://doi.org/10.1038/nprot.2017.066
[17]
Rambaut, A., Holmes, E.C., O’Toole, Á., Hill, V., McCrone, J.T., Ruis, C., et al. (2020) A Dynamic Nomenclature Proposal for SARS-CoV-2 Lineages to Assist Genomic Epidemiology. Nature Microbiology, 5, 1403-1407. https://doi.org/10.1038/s41564-020-0770-5
[18]
Zheng, P., Zhou, C., Ding, Y., Liu, B., Lu, L., Zhu, F., et al. (2023) Nanopore Sequencing Technology and Its Applications. MedComm, 4, e316. https://doi.org/10.1002/mco2.316
[19]
Carbo, E.C., Mourik, K., Boers, S.A., Munnink, B.O., Nieuwenhuijse, D., Jonges, M., et al. (2023) A Comparison of Five Illumina, Ion Torrent, and Nanopore Sequencing Technology-Based Approaches for Whole Genome Sequencing of SARS-CoV-2. European Journal of Clinical Microbiology & Infectious Diseases, 42, 701-713. https://doi.org/10.1007/s10096-023-04590-0
[20]
Tegally, H., San, J.E., Cotten, M., Moir, M., Tegomoh, B., Mboowa, G., et al. (2022) The Evolving SARS-CoV-2 Epidemic in Africa: Insights from Rapidly Expanding Genomic Surveillance. Science, 378, eabq5358. https://doi.org/10.1126/science.abq5358
[21]
Rashid, P.M.A. and Salih, G.F. (2022) Molecular and Computational Analysis of Spike Protein of Newly Emerged Omicron Variant in Comparison to the Delta Variant of SARS-CoV-2 in Iraq. Molecular Biology Reports, 49, 7437-7445. https://doi.org/10.1007/s11033-022-07545-4
[22]
Guo, Y., Han, J., Zhang, Y., He, J., Yu, W., Zhang, X., et al. (2022) SARS-CoV-2 Omicron Variant: Epidemiological Features, Biological Characteristics, and Clinical Significance. Frontiers in Immunology, 13, Article 877101. https://doi.org/10.3389/fimmu.2022.877101
[23]
Mohapatra, R.K., Kandi, V., Sarangi, A.K., Verma, S., Tuli, H.S., Chakraborty, S., et al. (2022) The Recently Emerged BA.4 and BA.5 Lineages of Omicron and Their Global Health Concerns Amid the Ongoing Wave of COVID-19 Pandemic—Correspondence. International Journal of Surgery, 103, Article 106698. https://doi.org/10.1016/j.ijsu.2022.106698
[24]
Hachmann, N.P., Miller, J., Collier, A.Y., Ventura, J.D., Yu, J., Rowe, M., et al. (2022) Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and Ba.5. New England Journal of Medicine, 387, 86-88. https://doi.org/10.1056/nejmc2206576
[25]
WHO (2020) WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19-11 March 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
[26]
Pearson, C., Silal, S., Li, M., Dushoff, J., Bolker, B. and Abbott, S. (2021) Bounding the Levels of Transmissibility & Immune Evasion of the Omicron Variant in South Africa. https://www.sacmcepidemicexplorer.co.za/downloads/Pearson_etal_Omicron.pdf
[27]
Hui, K.P.Y., Ho, J.C.W., Cheung, M.-C., Ng, K.-C., Ching, R.H.H., Lai, K.-L., et al. (2022) SARS-CoV-2 Omicron Variant Replication in Human Respiratory Tract ex vivo. Nature, 603, 715-720. https://www.researchsquare.com/article/rs-1189219/v1 https://doi.org/10.1038/s41586-022-04479-6
[28]
Oude Munnink, B.B. and Koopmans, M. (2023) Tracking SARS-CoV-2 Variants and Resources. Nature Methods, 20, 489-490. https://doi.org/10.1038/s41592-023-01833-y
[29]
World Health Organization (2023) Weekly Epidemiological Update on COVID-19-27 July 2023. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---27-july-2023
[30]
Zappa, M., Verdecchia, P. and Angeli, F. (2023) Severe Acute Respiratory Syndrome Coronavirus 2 Evolution: How Mutations Affect XBB.1.5 Variant. European Journal of Internal Medicine, 112, 128-132. https://doi.org/10.1016/j.ejim.2023.03.027
